FCM
PFE icon

Fourpath Capital Management’s Pfizer PFE Stock Holding History

Fourpath Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.31M Buy
54,219
+9,504
+21% +$249K 0.17% 100
2026
Q1 		$1.26M Buy
44,715
+5,179
+13% +$138K 0.18% 88
2025
Q4 		$984K Sell
39,536
-6,133
-13% -$155K 0.13% 102
2025
Q3 		$1.16M Buy
45,669
+8,814
+24% +$218K 0.17% 91
2025
Q2 		$893K Buy
36,855
+6,095
+20% +$142K 0.14% 101
2025
Q1 		$779K Buy
30,760
+7,987
+35% +$209K 0.14% 101
2024
Q4 		$604K Sell
22,773
-5,328
-19% -$145K 0.11% 123
2024
Q3 		$813K Buy
28,101
+3,425
+14% +$99.9K 0.15% 102
2024
Q2 		$690K Sell
24,676
-780
-3% -$21.5K 0.51% 47
2024
Q1 		$706K Buy
25,456
+2,838
+13% +$78.8K 0.49% 49
2023
Q4 		$651K Sell
22,618
-967
-4% -$29.2K 0.44% 47
2023
Q3 		$782K Sell
23,585
-504
-2% -$17.8K 0.59% 36
2023
Q2 		$884K Buy
24,089
+3,162
+15% +$123K 1.06% 27
2023
Q1 		$854K Buy
20,927
+3,933
+23% +$170K 0.6% 35
2022
Q4 		$871K Buy
16,994
+2,218
+15% +$106K 0.63% 39
2022
Q3 		$647K Sell
14,776
-966
-6% -$46.9K 0.44% 53
2022
Q2 		$825K Sell
15,742
-1,619
-9% -$82.5K 0.51% 45
2022
Q1 		$899K Buy
17,361
+4,023
+30% +$209K 0.36% 51
2021
Q4 		$788K Buy
+13,338
New +$661K 0.3% 63

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fourpath Capital Management's PFE Position: Q2 2026 in Review

Fourpath Capital Management increased its Pfizer (PFE) stake by 21% in Q2 2026, buying an estimated $249K and bringing the position to 54,219 shares worth $1.31M. The position accounts for 0.17% of the portfolio, ranked #100.

Fourpath Capital Management first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Fourpath Capital Management held 54,219 shares of Pfizer worth $1.31M as of Q2 2026.
  • Fourpath Capital Management bought 9,504 Pfizer shares in Q2 2026, an estimated $249K.
  • Pfizer made up 0.17% of Fourpath Capital Management's portfolio in Q2 2026, its #100 holding.
  • Fourpath Capital Management first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Fourpath Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.